At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 enrolled
Drug / intervention
Activa RCdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
In Brief
A Phase 4 clinical trial evaluating Activa RC for Parkinson's Disease and 2 related conditions. Completed, enrolled 100 participants across 11 sites in 6 countries.
Detailed Summary
The purpose of this study is to assess the recharge feature of the Activa RC System in patients who are receiving Deep Brain Stimulation (DBS) for Parkinson's Disease (PD), Essential Tremor (ET), or dystonia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease, Essential Tremor, Dystonia
CountriesAustria, France, Germany, Spain, United Kingdom, United States
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedOct 2009
Primary CompletionJul 2013
TodayJul 2026
First PostedOct 20, 2009
Enrollment StartJul 1, 2009
Primary CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 16.7 years ago
Interventions
Activa RCdevice
Patients receiving Activa RC as their first implantable neurostimulator or as a replacement implantable neurostimulator for deep brain stimulation